Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
European Child & Adolescent Psychiatry|October 14, 2009
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsJan Buitelaar, Rossella MedoriJournal of Psychiatric Practice|January 25, 2006
Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergenciesGlenn W Currier, Rossella MedoriSchizophrenia Research|November 11, 2006
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlatesRobin Emsley, Jonathan Rabinowitz, Rossella Medori, et al.International Journal of Psychiatry in Clinical Practice|June 12, 2014
Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot studyPeter Bräunig, Emilio Sacchetti, Rossella MedoriThe American Journal of Psychiatry|April 6, 2006
Time course for antipsychotic treatment response in first-episode schizophreniaRobin Emsley, Jonathan Rabinowitz, Rossella MedoriEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2005
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectableRossella Medori, Erik Mannaert, Gerhard GründerHuman Psychopharmacology|September 29, 2007
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patientsWerner Kissling, Per Glue, Rossella Medori, et al.Nature Reviews. Drug Discovery|October 13, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.Nature Reviews. Drug Discovery|September 29, 2018
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugsDelphine Charvin, Rossella Medori, Robert A Hauser, et al.International Clinical Psychopharmacology|February 13, 2007
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidoneMax Schmauss, Emilio Sacchetti, Jean-Pierre Kahn, et al.Pageof 4